Windtree Therapeutics (NASDAQ: WINT) shares are surging on Wednesday after the company was granted U.S. patent number 11,583,540 titled “Istaroxime-Containing Intravenous Formulation For The Treatment …

More Why Windtree Therapeutics Stock Is Soaring Videos